Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Saline in Premature Ovarian Insufficiency
NCT04922398Phase 2Unknown
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous platelet-rich plasma in premature ovarian insufficiency (POI) (2 arms). Primary endpoints: FSH hormonal changes at 3 months, vaginal ultrasound monitoring of the ovaries at 3 months and 4 more. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT04922398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04922398.